ENRIAV Trademark

Trademark Overview

On Friday, August 8, 2014, a trademark application was filed for ENRIAV with the United States Patent and Trademark Office. The USPTO has given the ENRIAV trademark a serial number of 86361144. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 9, 2018. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The ENRIAV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use
enriav

General Information

Serial Number86361144
Word MarkENRIAV
Filing DateFriday, August 8, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 9, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 6, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "ENRIAV".
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 18, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressChuo-ku, Tokyo 103-842
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressChuo-ku, Tokyo 103-842
JP

Trademark Events

Event DateEvent Description
Monday, April 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 9, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 4, 2017EXTENSION 5 GRANTED
Tuesday, August 1, 2017EXTENSION 5 FILED
Tuesday, August 1, 2017TEAS EXTENSION RECEIVED
Wednesday, February 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 13, 2017EXTENSION 4 GRANTED
Monday, February 13, 2017EXTENSION 4 FILED
Monday, February 13, 2017TEAS EXTENSION RECEIVED
Saturday, August 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2016EXTENSION 3 GRANTED
Tuesday, August 9, 2016EXTENSION 3 FILED
Tuesday, August 9, 2016TEAS EXTENSION RECEIVED
Friday, February 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2016EXTENSION 2 GRANTED
Wednesday, February 10, 2016EXTENSION 2 FILED
Wednesday, February 10, 2016TEAS EXTENSION RECEIVED
Friday, August 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2015EXTENSION 1 GRANTED
Tuesday, August 11, 2015EXTENSION 1 FILED
Thursday, August 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 11, 2015TEAS EXTENSION RECEIVED
Tuesday, March 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, November 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 28, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 28, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 28, 2014DATA MODIFICATION COMPLETED
Wednesday, November 26, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, November 24, 2014EXAMINER'S AMENDMENT ENTERED
Monday, November 24, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 24, 2014EXAMINERS AMENDMENT E-MAILED
Monday, November 24, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, November 24, 2014ASSIGNED TO EXAMINER
Saturday, August 23, 2014PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, August 20, 2014ASSIGNED TO LIE
Monday, August 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 14, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, August 12, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

enriav disease disorders infection inflammatory pain musculoskeletal inflammation fungal bacterial viral